Pine Labs Q4 FY26 Results Analysis: EBITDA Margin Beats Guidance, Operating Cash Flow Surges 8x
CompoundingAI Research
Updated May 25, 2026
2 min read
Pine Labs Ltd reported Q4 FY26 numbers. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | May 25, 2026 |
|---|
| Quarter | Q4 FY 2025-2026 |
|---|
| Revenue (Q4) | Rs. 2,710.59 Cr (+19.20% YoY) |
|---|
| PAT (Q4) | Rs. 112.51 Cr |
|---|
| EBITDA margin | 20.60% (+500 bps YoY) |
|---|
| EPS (Q4) | Rs. 1.05 |
|---|
| Market cap | Rs. 16,404.20 Cr |
|---|
| CMP | Rs. 142.84 |
|---|
Quarter Snapshot
Pine Labs delivered its first full year of profitability, with PAT swinging Rs.258 Cr from a loss to Rs.112.51 Cr. The adjusted EBITDA margin of 20.6% beat management's guidance of 19-20%, while operating cash flow surged 8x to Rs.395 Cr and debt was cut by 66%, strengthening the balance sheet significantly.
Key Investment Insights
Key Positives
- First full year of profitability with PAT of Rs.112.51 Cr vs loss of Rs.145.49 Cr in FY25.
- Adjusted EBITDA margin expanded 500 bps YoY to 20.6%, exceeding management guidance of 19-20%.
- Operating cash flow grew 8x YoY to Rs.395.39 Cr from Rs.49.72 Cr.
- Total debt reduced 65.9% to Rs.282.87 Cr from Rs.829.49 Cr, improving net worth by 68.1%.
- International revenue grew at 44% 3-year CAGR, now 15% of total revenue.
- Gross Transaction Value grew 50% YoY to $194 Bn, indicating monetization headroom.
Risk Factors
- Subsidiaries create a 25% drag on consolidated PAT, with a loss of Rs.37.37 Cr in FY26.
- GST demand of Rs.37.33 Cr contested via appeal, representing a contingent liability.
- Revenue declined 5.9% QoQ in Q4 FY26, though partly seasonal.
- Issuing & Acquiring segment contribution margin compressed 550 bps YoY to 55.4% in Q4.
Disclaimer: This is an AI-generated analysis based on public filings. It is not investment advice, not a recommendation to buy/sell/hold any security, and is not prepared by a SEBI-registered Research Analyst or Investment Adviser.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now